M
Michael Aviram
Researcher at Technion – Israel Institute of Technology
Publications - 489
Citations - 32705
Michael Aviram is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 94, co-authored 479 publications receiving 31141 citations. Previous affiliations of Michael Aviram include University of Tromsø & Steward Health Care System.
Papers
More filters
Journal ArticleDOI
Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (M-CSF-R)
TL;DR: Ox-LDL induces monocyte differentiation to macrophages in vivo and this phenomenon involves activation of the M-CSF-receptor, as evidenced by morphologic, phenotypic, and functional properties.
Journal ArticleDOI
Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy
TL;DR: The change in the plasma HDL concentrations of the hypothyroid group questions the relationship of this group to arteriosclerosis, but complete correction may be related to duration of therapy.
Journal ArticleDOI
Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux.
TL;DR: It is concluded that EVOO possesses beneficial antiatherogenic effects, and its enrichment with GTPPs further improved these effects, leading to the attenuation of atherosclerosis development.
Journal ArticleDOI
Effect of Dietary Supplementation of Red or White Wine on Human Blood Chemistry, Hematology and Coagulation: Favorable Effect of Red Wine on Plasma High-Density Lipoprotein
Alexandra Lavy,Bianca Fuhrman,Arie Markel,Gertrude Dankner,Ami Ben-Amotz,Dita Presser,Michael Aviram +6 more
TL;DR: It is concluded that the major effect of red-wine supplementation (about 40 g of alcohol per day for a period of 2 weeks) was a significant increase in plasma HDL concentration which may contribute to the reduced risk for cardiovascular diseases observed in red- wine drinkers.
Journal ArticleDOI
Paraoxonase 1 (PON1) is present in postprandial chylomicrons
TL;DR: It is concluded that postprandial chylomicrons contain PON1, which may function in the removal of atherogenic oxidized lipids and inhibit copper ion-induced LDL oxidation, secondary to hydrolysis of lipid peroxides, a phenomenon which could be related, at least in part, to thechylomicron Pon1 content.